Charlotte King, Joanna C. Fowler, Jonas Koeppel, Kourosh Saeb-Parsy, Swee Hoe Ong, Moritz Gerstung, Benjamin A. Hall, Eleanor Earp, Amer Durrani, Krishnaa Mahububani, Kate Fife, David Shorthouse, Stefan C. Dentro, Christopher J. Bryant, Sood R, Michael W. J. Hall, Philip H. Jones, Amit Roshan, Edward Rytina, Doreen Milne, David Fernandez-Antoran, Shorthouse, David [0000-0002-3207-3584], Roshan, Amit [0000-0002-2034-2759], Saeb-Parsy, Kourosh [0000-0002-0633-3696], Hall, Benjamin [0000-0003-0355-2946], Jones, Philip [0000-0002-5904-795X], and Apollo - University of Cambridge Repository
Skin cancer risk varies substantially across the body, yet how this relates to the mutations found in normal skin is unknown. Here we mapped mutant clones in skin from high- and low-risk sites. The density of mutations varied by location. The prevalence of NOTCH1 and FAT1 mutations in forearm, trunk, and leg skin was similar to that in keratinocyte cancers. Most mutations were caused by ultraviolet light, but mutational signature analysis suggested differences in DNA-repair processes between sites. Eleven mutant genes were under positive selection, with TP53 preferentially selected in the head and FAT1 in the leg. Fine-scale mapping revealed 10% of clones had copy-number alterations. Analysis of hair follicles showed mutations in the upper follicle resembled adjacent skin, but the lower follicle was sparsely mutated. Normal skin is a dense patchwork of mutant clones arising from competitive selection that varies by location. Significance: Mapping mutant clones across the body reveals normal skin is a dense patchwork of mutant cells. The variation in cancer risk between sites substantially exceeds that in mutant clone density. More generally, mutant genes cannot be assigned as cancer drivers until their prevalence in normal tissue is known. See related commentary by De Dominici and DeGregori, p. 227. This article is highlighted in the In This Issue feature, p. 211